Thermo Fisher expects lasting benefits to bill targeting Chinese service providers

Ther­mo Fish­er said it will be a “long-term ben­e­fi­cia­ry” of bio­phar­ma cus­tomers lo­cal­iz­ing their sup­ply chains, giv­en most of its net­work is based in the US and Eu­rope.

Clients are think­ing more se­ri­ous­ly about where their man­u­fac­tur­ing part­ners are based in light of po­ten­tial dis­rup­tions such as the Biose­cure Act, Ther­mo’s CEO Marc Casper said dur­ing its first-quar­ter earn­ings call. “Cus­tomers are turn­ing to us more than ever … It’s our job to help our cus­tomers through shift­ing land­scapes,” he added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.